National service evaluation for paclitaxel HSRs

Dear BOPA members,

We are all very aware of concerns from our members regarding the ongoing supply shortages of ranitidine. Many hospitals will be forced to amend pre-medication regimens to an alternative where there is sparse experience and it is imperative that we collect data that assures us that patient safety is not compromised.

As Co-chair of BOPA, I would like to invite you to take part in a national service evaluation of paclitaxel pre-medication regimes designed by myself in collaboration with Calum Polwart and Pinkie Chambers. Calum has created a bespoke data collection tool (in Excel format) to minimise the administrative burden.

We strongly encourage you to collaborate on this project, so collectively we can gain a better understanding of the impact of changes in practice results from the shortage.

What to do next?

Email me to let us know you are participating ([email protected]). I will send you the data collection tool and an instruction sheet for participants, and we can then keep in touch with you throughout the evaluation period.

Although we have logged the evaluation with the BOPA executive committee and A&R subcommittee, you will still need to register your data collection as a service evaluation at your Trust.

Data collection will take place over a six-month period from 1st July to 31st December (the end date may be amended depending on the amount of data received). We will keep a check on numbers collected and complete an interim analysis as soon as possible. Results of the interim analysis as well as the final results will be presented to participating centres in a timely fashion to assist in clinical decision-making.

If you have any concerns or queries, please contact a member of the team via the email addresses given below.

I will look forward to hearing from you!

Best Wishes

Emma Foreman
Co-chair, British Oncology Pharmacy Association
www.bopa.org.uk

Contacts:
[email protected]
[email protected]
[email protected]
[email protected]

Latest News

By BOPA Committee on 28th March 2024

Haematology Patient and Carers Congress (HPCC)

Dear BOPA Members, Please share with your patients, their families, carers, and colleagues…. A first ever, cross-disease site, Haematology Patient and Carers Congress (HPCC) 2024, is being held at the…

Read article
By BOPA on 20th March 2024

BSIO Annual Conference 2024

BSIO (British Society for Integrative Oncology) is the leading professional organisation for integrative oncology in the UK. Our goal is to promote the integration of evidence-informed conventional, nutritional, lifestyle and complementary…

Read article
By BOPA on 20th March 2024

New Members to the BOPA Executive Committee

Please join us in welcoming the new roles for the coming year on the BOPA Executive Committee.   Change of Role: Shereen Nabhani-Gebara will take over as Vice Chair as…

Read article
By BOPA GAP on 20th March 2024

Published: BOPA Guide to Producing a Position Statement

As an organisation BOPA represents the interests of its members and the wider oncology pharmacy workforce by developing and adopting position statements in response to changes in healthcare policy, or…

Read article